Dr Brian Jones
- Honorary Professor (School of Infection & Immunity)
email:
Brian.Jones@glasgow.ac.uk
Immunology Infection and Inflamm, Bhf Cardiovascular Research Cent
Publications
2024
Heggie, Robert, Jaiswal, Nishant ORCID: https://orcid.org/0000-0001-5511-4572, McCartney, Elaine
ORCID: https://orcid.org/0000-0002-0260-4161, Moss, Jon, Menne, Tobias, Jones, Brian, Boyd, Kathleen
ORCID: https://orcid.org/0000-0002-9764-0113, Soulis, Eileen, Hawkins, Neil
ORCID: https://orcid.org/0000-0003-3199-221X and Wu, Olivia
ORCID: https://orcid.org/0000-0002-0570-6016
(2024)
Central venous access devices for the delivery of systemic anticancer therapy: an economic evaluation.
Value in Health, 27(1),
pp. 7-14.
(doi: 10.1016/j.jval.2023.09.2996)
(PMID:37844662)
2022
Helmstetter, N. et al. (2022) Population genetics and microevolution of clinical Candida glabrata reveals recombinant sequence types and hyper-variation within mitochondrial genomes, virulence genes and drug-targets. Genetics, 221(1), iyac031. (doi: 10.1093/genetics/iyac031) (PMID:35199143)
2021
Moss, J. G. et al. (2021) Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial. Lancet, 398(10298), pp. 403-415. (doi: 10.1016/S0140-6736(21)00766-2) (PMID:34297997)
Wu, O. et al. (2021) Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT. Health Technology Assessment, 25(47), (doi: 10.3310/hta25470)
2018
Delpech, Pierre, ALeryan, Muna, Jones, Brian, Gemmell, Curtis and Lang, Sue (2018) An in vitro evaluation of the efficacy of tedizolid: implications for the treatment of skin and soft tissue infections. Diagnostic Microbiology and Infectious Disease, 91(1), pp. 93-97. (doi: 10.1016/j.diagmicrobio.2018.01.006) (PMID:29452993)
2017
Jones, Brian L., Richardson, Malcolm D., Ingram, Patricia M. and Agrawal, Samir G. (2017) A CONSORT analysis of randomised controlled trials for the treatment of invasive aspergillosis. Medical Mycology, 55(6), pp. 605-613. (doi: 10.1093/mmy/myw133) (PMID:27915306)
2016
Rajendran, R. et al. (2016) Integrating Candida albicans metabolism with biofilm heterogeneity by transcriptome mapping. Scientific Reports, 6, 35436. (doi: 10.1038/srep35436) (PMID:27765942) (PMCID:PMC5073228)
Rajendran, Ranjith, Sherry, Leighann ORCID: https://orcid.org/0000-0002-0493-6135, Ashutosh, Deshpande, Johnson, Elizabeth M., Hanson, Mary F., Williams, Craig, Munro, Carol, Jones, Brian L. and Ramage, Gordon
ORCID: https://orcid.org/0000-0002-0932-3514
(2016)
A prospective surveillance study of candidaemia: Epidemiology, risk factors, antifungal treatment and outcome in hospitalised patients.
Frontiers in Microbiology, 7,
915.
(doi: 10.3389/fmicb.2016.00915)
(PMID:27379047)
(PMCID:PMC4910670)
Rajendran, Ranjith, Sherry, Leighann ORCID: https://orcid.org/0000-0002-0493-6135, Nile, Christopher
ORCID: https://orcid.org/0000-0001-8218-2167, Sherriff, Andrea
ORCID: https://orcid.org/0000-0002-1016-037X, Johnson, Elizabeth, Hanson, Mary, Williams, Craig, Munro, Carol, Jones, Brian and Ramage, Gordon
ORCID: https://orcid.org/0000-0002-0932-3514
(2016)
Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection – Scotland, 2012-2013.
Clinical Microbiology and Infection, 22(1),
pp. 87-93.
(doi: 10.1016/j.cmi.2015.09.018)
(PMID:26432192)
2015
Rajendran, Ranjith, Mowat, Eilidh, Jones, Brian, Williams, Craig and Ramage, Gordon ORCID: https://orcid.org/0000-0002-0932-3514
(2015)
Prior in vitro exposure to voriconazole confers resistance to amphotericin B in aspergillus fumigatus biofilms.
International Journal of Antimicrobial Agents, 46(3),
pp. 342-345.
(doi: 10.1016/j.ijantimicag.2015.03.006)
(PMID:25979638)
2014
Cordina, Claire J., Culleton, Richard, Jones, Brian L., Smith, Catherine C., MacConnachie, Alisdair A., Coyne, Michael J. and Alexander, Claire L. (2014) Plasmodium knowlesi: clinical presentation and laboratory diagnosis of the first human case in a Scottish traveler. Journal of Travel Medicine, 21(5), pp. 357-360. (doi: 10.1111/jtm.12131) (PMID:24861374)
Sherry, L. et al. (2014) Biofilms formed by Candida albicans bloodstream isolates display phenotypic and transcriptional heterogeneity that are associated with resistance and pathogenicity. BMC Microbiology, 14(1), p. 182. (doi: 10.1186/1471-2180-14-182)
2013
Ramage, Gordon ORCID: https://orcid.org/0000-0002-0932-3514, Jose, Anto, Sherry, Leighann
ORCID: https://orcid.org/0000-0002-0493-6135, Lappin, David F., Jones, Brian and Williams, Craig
(2013)
Liposomal amphotericin B displays rapid dose-dependent activity against candida albicans biofilms.
Antimicrobial Agents and Chemotherapy, 57(5),
pp. 2369-2371.
(doi: 10.1128/AAC.02344-12)
2012
Agrawal, S. et al. (2012) A practical critique of antifungal treatment guidelines for haemato-oncologists. Critical Reviews in Microbiology, 38(3), pp. 203-216. (doi: 10.3109/1040841X.2011.645521)
Marek, A., McColl, K., Going, J., Spence, G., Jones, B. and Alexander, C. (2012) What a professor learned about Cyclospora cayetanensis by attending Digestive Diseases Week Conference in Chicago. American Journal of Gastroenterology, 107(7), pp. 1109-1111. (doi: 10.1038/ajg.2012.74)
2011
Ramage, G. ORCID: https://orcid.org/0000-0002-0932-3514, Rajendran, R., Gutierrez-Correa, M., Jones, B. and Williams, C.
(2011)
Aspergillus biofilms: clinical and industrial significance.
FEMS Microbiology Letters, 324(2),
pp. 89-97.
(doi: 10.1111/j.1574-6968.2011.02381.x)
Cornely, O.A., Aversa, F., Cook, P., Jones, B., Michallet, M., Shea, T. and Vallejo, C. (2011) Evaluating the role of prophylaxis in the management of invasive fungal infections in patients with hematologic malignancy. European Journal of Haematology, 87(4), pp. 289-301. (doi: 10.1111/j.1600-0609.2011.01682.x)
2010
Ramage, Gordon ORCID: https://orcid.org/0000-0002-0932-3514, Culshaw, Shauna
ORCID: https://orcid.org/0000-0002-9653-5629, Jones, Brian and Williams, Craig
(2010)
Are we any closer to beating the biofilm: novel methods of biofilm control.
Current Opinion in Infectious Diseases, 23(6),
pp. 560-566.
(doi: 10.1097/QCO.0b013e32833e5850)
(PMID:20717027)
Articles
Heggie, Robert, Jaiswal, Nishant ORCID: https://orcid.org/0000-0001-5511-4572, McCartney, Elaine
ORCID: https://orcid.org/0000-0002-0260-4161, Moss, Jon, Menne, Tobias, Jones, Brian, Boyd, Kathleen
ORCID: https://orcid.org/0000-0002-9764-0113, Soulis, Eileen, Hawkins, Neil
ORCID: https://orcid.org/0000-0003-3199-221X and Wu, Olivia
ORCID: https://orcid.org/0000-0002-0570-6016
(2024)
Central venous access devices for the delivery of systemic anticancer therapy: an economic evaluation.
Value in Health, 27(1),
pp. 7-14.
(doi: 10.1016/j.jval.2023.09.2996)
(PMID:37844662)
Helmstetter, N. et al. (2022) Population genetics and microevolution of clinical Candida glabrata reveals recombinant sequence types and hyper-variation within mitochondrial genomes, virulence genes and drug-targets. Genetics, 221(1), iyac031. (doi: 10.1093/genetics/iyac031) (PMID:35199143)
Moss, J. G. et al. (2021) Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial. Lancet, 398(10298), pp. 403-415. (doi: 10.1016/S0140-6736(21)00766-2) (PMID:34297997)
Wu, O. et al. (2021) Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT. Health Technology Assessment, 25(47), (doi: 10.3310/hta25470)
Delpech, Pierre, ALeryan, Muna, Jones, Brian, Gemmell, Curtis and Lang, Sue (2018) An in vitro evaluation of the efficacy of tedizolid: implications for the treatment of skin and soft tissue infections. Diagnostic Microbiology and Infectious Disease, 91(1), pp. 93-97. (doi: 10.1016/j.diagmicrobio.2018.01.006) (PMID:29452993)
Jones, Brian L., Richardson, Malcolm D., Ingram, Patricia M. and Agrawal, Samir G. (2017) A CONSORT analysis of randomised controlled trials for the treatment of invasive aspergillosis. Medical Mycology, 55(6), pp. 605-613. (doi: 10.1093/mmy/myw133) (PMID:27915306)
Rajendran, R. et al. (2016) Integrating Candida albicans metabolism with biofilm heterogeneity by transcriptome mapping. Scientific Reports, 6, 35436. (doi: 10.1038/srep35436) (PMID:27765942) (PMCID:PMC5073228)
Rajendran, Ranjith, Sherry, Leighann ORCID: https://orcid.org/0000-0002-0493-6135, Ashutosh, Deshpande, Johnson, Elizabeth M., Hanson, Mary F., Williams, Craig, Munro, Carol, Jones, Brian L. and Ramage, Gordon
ORCID: https://orcid.org/0000-0002-0932-3514
(2016)
A prospective surveillance study of candidaemia: Epidemiology, risk factors, antifungal treatment and outcome in hospitalised patients.
Frontiers in Microbiology, 7,
915.
(doi: 10.3389/fmicb.2016.00915)
(PMID:27379047)
(PMCID:PMC4910670)
Rajendran, Ranjith, Sherry, Leighann ORCID: https://orcid.org/0000-0002-0493-6135, Nile, Christopher
ORCID: https://orcid.org/0000-0001-8218-2167, Sherriff, Andrea
ORCID: https://orcid.org/0000-0002-1016-037X, Johnson, Elizabeth, Hanson, Mary, Williams, Craig, Munro, Carol, Jones, Brian and Ramage, Gordon
ORCID: https://orcid.org/0000-0002-0932-3514
(2016)
Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection – Scotland, 2012-2013.
Clinical Microbiology and Infection, 22(1),
pp. 87-93.
(doi: 10.1016/j.cmi.2015.09.018)
(PMID:26432192)
Rajendran, Ranjith, Mowat, Eilidh, Jones, Brian, Williams, Craig and Ramage, Gordon ORCID: https://orcid.org/0000-0002-0932-3514
(2015)
Prior in vitro exposure to voriconazole confers resistance to amphotericin B in aspergillus fumigatus biofilms.
International Journal of Antimicrobial Agents, 46(3),
pp. 342-345.
(doi: 10.1016/j.ijantimicag.2015.03.006)
(PMID:25979638)
Cordina, Claire J., Culleton, Richard, Jones, Brian L., Smith, Catherine C., MacConnachie, Alisdair A., Coyne, Michael J. and Alexander, Claire L. (2014) Plasmodium knowlesi: clinical presentation and laboratory diagnosis of the first human case in a Scottish traveler. Journal of Travel Medicine, 21(5), pp. 357-360. (doi: 10.1111/jtm.12131) (PMID:24861374)
Sherry, L. et al. (2014) Biofilms formed by Candida albicans bloodstream isolates display phenotypic and transcriptional heterogeneity that are associated with resistance and pathogenicity. BMC Microbiology, 14(1), p. 182. (doi: 10.1186/1471-2180-14-182)
Ramage, Gordon ORCID: https://orcid.org/0000-0002-0932-3514, Jose, Anto, Sherry, Leighann
ORCID: https://orcid.org/0000-0002-0493-6135, Lappin, David F., Jones, Brian and Williams, Craig
(2013)
Liposomal amphotericin B displays rapid dose-dependent activity against candida albicans biofilms.
Antimicrobial Agents and Chemotherapy, 57(5),
pp. 2369-2371.
(doi: 10.1128/AAC.02344-12)
Agrawal, S. et al. (2012) A practical critique of antifungal treatment guidelines for haemato-oncologists. Critical Reviews in Microbiology, 38(3), pp. 203-216. (doi: 10.3109/1040841X.2011.645521)
Marek, A., McColl, K., Going, J., Spence, G., Jones, B. and Alexander, C. (2012) What a professor learned about Cyclospora cayetanensis by attending Digestive Diseases Week Conference in Chicago. American Journal of Gastroenterology, 107(7), pp. 1109-1111. (doi: 10.1038/ajg.2012.74)
Ramage, G. ORCID: https://orcid.org/0000-0002-0932-3514, Rajendran, R., Gutierrez-Correa, M., Jones, B. and Williams, C.
(2011)
Aspergillus biofilms: clinical and industrial significance.
FEMS Microbiology Letters, 324(2),
pp. 89-97.
(doi: 10.1111/j.1574-6968.2011.02381.x)
Cornely, O.A., Aversa, F., Cook, P., Jones, B., Michallet, M., Shea, T. and Vallejo, C. (2011) Evaluating the role of prophylaxis in the management of invasive fungal infections in patients with hematologic malignancy. European Journal of Haematology, 87(4), pp. 289-301. (doi: 10.1111/j.1600-0609.2011.01682.x)
Ramage, Gordon ORCID: https://orcid.org/0000-0002-0932-3514, Culshaw, Shauna
ORCID: https://orcid.org/0000-0002-9653-5629, Jones, Brian and Williams, Craig
(2010)
Are we any closer to beating the biofilm: novel methods of biofilm control.
Current Opinion in Infectious Diseases, 23(6),
pp. 560-566.
(doi: 10.1097/QCO.0b013e32833e5850)
(PMID:20717027)